Thailand
· Delayed Price · Currency is THB NAM Statistics
Total Valuation
Namwiwat Medical Corporation Public Company has a market cap or net worth of THB 3.42 billion. The enterprise value is 2.70 billion.
| Market Cap | 3.42B |
| Enterprise Value | 2.70B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Namwiwat Medical Corporation Public Company has 700.00 million shares outstanding. The number of shares has increased by 2,437.32% in one year.
| Shares Outstanding | 700.00M |
| Shares Change (YoY) | +2,437.32% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 59.14% |
| Owned by Institutions (%) | 2.85% |
| Float | 93.28M |
Valuation Ratios
The trailing PE ratio is 20.09 and the forward PE ratio is 15.74.
| PE Ratio | 20.09 |
| Forward PE | 15.74 |
| PS Ratio | 3.47 |
| PB Ratio | 1.75 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.24, with an EV/FCF ratio of -30.80.
| EV / Earnings | 16.67 |
| EV / Sales | 2.88 |
| EV / EBITDA | 12.24 |
| EV / EBIT | 13.89 |
| EV / FCF | -30.80 |
Financial Position
The company has a current ratio of 5.61, with a Debt / Equity ratio of 10.63.
| Current Ratio | 5.61 |
| Quick Ratio | 4.31 |
| Debt / Equity | 10.63 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | -2.37 |
| Interest Coverage | 13.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 2.31M |
| Profits Per Employee | 399,023 |
| Employee Count | 406 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 4.76 |
| 200-Day Moving Average | 5.30 |
| Relative Strength Index (RSI) | 61.42 |
| Average Volume (20 Days) | 119,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Namwiwat Medical Corporation Public Company had revenue of THB 937.11 million and earned 162.00 million in profits. Earnings per share was 0.24.
| Revenue | 937.11M |
| Gross Profit | 420.16M |
| Operating Income | 194.47M |
| Pretax Income | 201.44M |
| Net Income | 162.00M |
| EBITDA | 217.00M |
| EBIT | 194.47M |
| Earnings Per Share (EPS) | 0.24 |
Balance Sheet
The company has 924.41 million in cash and 207.51 million in debt, giving a net cash position of 716.89 million or 1.02 per share.
| Cash & Cash Equivalents | 924.41M |
| Total Debt | 207.51M |
| Net Cash | 716.89M |
| Net Cash Per Share | 1.02 |
| Equity (Book Value) | 1.95B |
| Book Value Per Share | 2.79 |
| Working Capital | 1.47B |
Cash Flow
In the last 12 months, operating cash flow was -42.99 million and capital expenditures -44.69 million, giving a free cash flow of -87.69 million.
| Operating Cash Flow | -42.99M |
| Capital Expenditures | -44.69M |
| Free Cash Flow | -87.69M |
| FCF Per Share | -0.13 |
Margins
Gross margin is 44.84%, with operating and profit margins of 20.75% and 17.29%.
| Gross Margin | 44.84% |
| Operating Margin | 20.75% |
| Pretax Margin | 21.50% |
| Profit Margin | 17.29% |
| EBITDA Margin | 23.16% |
| EBIT Margin | 20.75% |
| FCF Margin | -9.36% |
Dividends & Yields
This stock pays an annual dividend of 0.09, which amounts to a dividend yield of 1.84%.
| Dividend Per Share | 0.09 |
| Dividend Yield | 1.84% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 82.95% |
| Buyback Yield | -2,437.32% |
| Shareholder Yield | -2,435.48% |
| Earnings Yield | 4.98% |
| FCF Yield | -2.57% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |